Previous Article | Next Article ![]()
Laboratorio di Microbiologia Molecolare e Biotecnologia (LA.M.M.B.), Dipartimento di Biologia Molecolare, Università di Siena, 53100 Siena, Italy; Department of Infectious Disease Immunity, Staten Serum Institute, Copenhagen, Denmark
* To whom correspondence should be addressed. Email:
medaglini{at}unisi.it.
The primary activation of T-helper and T-cytotoxic cells following mucosal immunization with recombinant Streptococcus gordonii was studied in vivo by adoptive transfer of ovalbumin (OVA)-specific transgenic CD8+ (OT-I) and CD4+ (OT-II) T cells. A recombinant strain, expressing on the surface the vaccine antigen Ag85B-ESAT-6 from Mycobacterium tuberculosis fused to OVA T-helper and T-cytotoxic epitopes (323-339 and 257-264), was constructed and used to immunize C57BL/6 mice by the intranasal route. Recombinant bacteria, but not wild type, induced OVA-specific CD4+ and CD8+ T-cell clonal expansion in cervical lymph nodes, lung and spleen. OVA-specific CD4+ and CD8+ T-cell proliferation appeared first in cervical lymph nodes and later in the spleen, suggesting a possible migration of activated cells from the inductive site to the systemic district. A significant correlation between the percentage of CD4+ and CD8+ proliferating T cells was observed in each animal. The expression of CD69, CD44 and CD45RB on proliferating T lymphocytes changed as a function of cell division number, confirming T-cell activation following antigen encounter. These data indicate that intranasal immunization with recombinat S. gordonii is capable of inducing primary activation of naive antigen-specific CD4+ and CD8+ T cells both locally and systemically.
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria
![]()
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»